A citation-based method for searching scientific literature

Jeffrey N Weitzel, Kathleen R Blazer, Deborah J MacDonald, Julie O Culver, Kenneth Offit. CA Cancer J Clin 2011
Times Cited: 143



Serena Masciari, Deborah A Dillon, Michelle Rath, Mark Robson, Jeffrey N Weitzel, Judith Balmana, Stephen B Gruber, James M Ford, David Euhus, Alexandra Lebensohn, Melinda Telli, Stephen M Pochebit, Georgios Lypas, Judy E Garber. Breast Cancer Res Treat 2012
Times Cited: 88




List of shared articles



Times cited

Recommendations for Advancing the Diagnosis and Management of Hereditary Breast and Ovarian Cancer in Brazil.
Maria Isabel Achatz, Maira Caleffi, Rodrigo Guindalini, Renato Moretti Marques, Angelica Nogueira-Rodrigues, Patricia Ashton-Prolla. JCO Glob Oncol 2020
3

Prevalence of germline mutations in the TP53 gene in patients with early-onset breast cancer in the Mexican population.
Lenny N Gallardo-Alvarado, María Teresa Tusié-Luna, María Isabel Tussié-Luna, José Díaz-Chávez, Yayoi X Segura, Enrique Bargallo-Rocha, Cynthia Villarreal, Luis A Herrera-Montalvo, Enrique M Herrera-Medina, David F Cantu-de Leon. BMC Cancer 2019
5

An update on genetic risk assessment and prevention: the role of genetic testing panels in breast cancer.
Carolyn Piccinin, Seema Panchal, Nicholas Watkins, Raymond H Kim. Expert Rev Anticancer Ther 2019
8

Somatic TP53 variants frequently confound germ-line testing results.
Jeffrey N Weitzel, Elizabeth C Chao, Bita Nehoray, Lily R Van Tongeren, Holly LaDuca, Kathleen R Blazer, Thomas Slavin, D A B M D Facmg, Tina Pesaran, Christina Rybak,[...]. Genet Med 2018
55

The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk.
Thomas P Slavin, Kara N Maxwell, Jenna Lilyquist, Joseph Vijai, Susan L Neuhausen, Steven N Hart, Vignesh Ravichandran, Tinu Thomas, Ann Maria, Danylo Villano,[...]. NPJ Breast Cancer 2017
66